The American Hospital Association has called on federal regulators to intervene after Eli Lilly sent warning letters to 340B hospitals threatening to cut off discounted drug pricing unless they submit ...

The 340B drug plan language that was recently added into Senate Bill 494 risks increasing costs for the very patients it ...

On October 26, 2023, the Health Resources and Services Administration (HRSA) issued a Notice to “inform and remind” 340B Program covered entities that to be considered eligible for the 340B program, ...

It's time for lawmakers to finally fix the 340B drug prescription program so it truly benefits our state's most vulnerable ...

Federal judge permanently blocks North Dakota 340B drug law, ruling it unconstitutional and halting enforcement against ...

Despite dramatic expansion over the past 34 years, many rural and underserved hospitals continue to face significant ...

Senator calls on Congress to increase oversight of the 340B Drug Pricing Program by requiring participating providers to complete annual reports on program savings and revenues. If your health system ...

The 340B Program has continued to undergo significant upheaval in 2024 that has the potential to bring about impactful changes to how the 340B Program operates moving forward. These developments have ...

Just days and weeks away from key deadlines, the hospital industry’s leading trade organization is still calling for the administration to scrap a one-year pilot of drugmakers’ preferred approach to ...

Congress created the 340B drug discount program in 1992 with a simple premise: allow hospitals and federal grantees serving a ...

One of the critical components for Mainers as they navigate the medical quagmire of insurance, providers and treatment is obtaining effective and safe drugs. Cancer treatment is often a long, taxing ...